Legato Merger Corp. IV Files S-1 for $200M SPAC IPO

TL;DR

**Avoid this SPAC; the massive dilution and inherent conflicts of interest for management make it a high-risk bet for public shareholders.**

AI Summary

Legato Merger Corp. IV (LEGO-WT) filed an S-1 for an initial public offering of 20,000,000 units at $10.00 per unit, aiming to raise $200,000,000. Each unit comprises one ordinary share and one-third of one warrant, with each whole warrant exercisable at $11.50 per share. The SPAC intends to target businesses in the infrastructure, industrial, artificial intelligence, and technology industries, but has no specific target identified. Initial shareholders acquired 7,666,667 founder shares for a nominal $25,000, or approximately $0.003 per share, leading to immediate and substantial dilution for public shareholders. The company faces a 24-month deadline (or 27 months with a letter of intent) to complete a business combination, after which public shares will be redeemed at a pro rata portion of the trust account, less up to $100,000 for liquidation expenses. BTIG, LLC, the sole book-running manager, will receive up to $10,000,000 in underwriting discounts and commissions, including $7,000,000 in deferred commissions and 50,000 representative founder shares. Management's low cost basis for founder shares creates potential conflicts of interest, incentivizing a deal even if unprofitable for public shareholders.

Why It Matters

This S-1 filing signals Legato Merger Corp. IV's entry into the SPAC market, aiming to raise $200 million to acquire a target in high-growth sectors like AI and technology. For investors, the significant dilution from founder shares purchased at $0.003 each presents an immediate concern, alongside potential conflicts of interest for management. The 24-month timeline for a business combination puts pressure on the management team, which could lead to suboptimal deal selection. In a competitive SPAC landscape, the lack of a specific target and the broad industry focus may make it challenging to differentiate, impacting the company's ability to attract a high-quality merger partner.

Risk Assessment

Risk Level: high — The risk level is high due to the immediate and substantial dilution for public shareholders, as initial shareholders acquired 7,666,667 founder shares for only $25,000, or approximately $0.003 per share. Additionally, significant conflicts of interest exist, as management's low cost basis for founder shares creates an incentive to complete a transaction, even if it's unprofitable for public shareholders, to avoid their founder shares and private units becoming worthless if a deal isn't completed within 24-27 months.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the significant dilution and potential conflicts of interest before considering an investment in Legato Merger Corp. IV. Given the high risk, a wait-and-see approach until a definitive business combination is announced, and its terms are fully disclosed, would be prudent.

Financial Highlights

debt To Equity

N/A

revenue

N/A

operating Margin

N/A

total Assets

$200,000,000 (IPO proceeds)

total Debt

$0

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

$200,000,000 (IPO proceeds)

revenue Growth

N/A

Key Numbers

• $200,000,000 — Total Public Offering Price (Targeted capital raise from the IPO)
• 20,000,000 — Units Offered (Number of units available in the IPO)
• $10.00 — Price Per Unit (Initial offering price for each unit)
• $11.50 — Warrant Exercise Price (Price at which each whole warrant can purchase one ordinary share)
• 7,666,667 — Founder Shares (Number of ordinary shares held by initial shareholders prior to the offering)
• $25,000 — Aggregate Founder Share Purchase Price (Total amount paid by initial shareholders for founder shares)
• $0.003 — Founder Share Price Per Share (Nominal price per share paid by initial shareholders)
• 24 months — Time to Complete Business Combination (Deadline for the SPAC to complete an initial business combination)
• $10,000,000 — Underwriting Discounts and Commissions (Total compensation for BTIG, LLC, including deferred commissions)
• $5,150,000 — Private Placement Purchase Price (Total purchase price for 515,000 private units by initial shareholders and BTIG)

Key Players & Entities

• Legato Merger Corp. IV (company) — Registrant for S-1 filing
• Gregory Monahan (person) — Chief Executive Officer of Legato Merger Corp. IV
• David A. Miller (person) — Counsel from Graubard Miller
• Jeffrey M. Gallant (person) — Counsel from Graubard Miller
• Alexandra Low (person) — Counsel from Appleby (Cayman) Ltd.
• Mitchell S. Nussbaum (person) — Counsel from Loeb & Loeb LLP
• Terry Bokosha (person) — Counsel from Loeb & Loeb LLP
• BTIG, LLC (company) — Sole Book-Running Manager and underwriter representative
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for S-1 filing
• Continental Stock Transfer & Trust Company (company) — Trustee for the trust account

FAQ

Risk Factors

• Redemption Risk [high — financial]: Public shareholders may redeem their shares if a business combination is not completed within 24 months (or 27 months with an LOI). This could lead to a significant portion of the IPO proceeds being returned to shareholders, reducing the capital available for a target company and potentially forcing the SPAC to pursue a less attractive acquisition.
• Dilution from Founder Shares [high — financial]: Initial shareholders acquired 7,666,667 founder shares for $25,000 ($0.003 per share). This low cost basis creates a significant incentive to complete a transaction, even if it is not optimal for public shareholders, due to the potential for substantial personal gains upon a successful merger, leading to immediate and significant dilution for public investors.
• Target Identification Uncertainty [medium — market]: The SPAC has not identified a specific target business and will pursue opportunities in infrastructure, industrial, AI, and technology. The success of the SPAC is highly dependent on management's ability to identify and execute a favorable business combination within the 24-month timeframe, facing competition from other SPACs and traditional M&A.
• Underwriting Fees and Deferred Commissions [medium — financial]: BTIG, LLC, as the sole book-running manager, is entitled to up to $10,000,000 in underwriting discounts and commissions, including $7,000,000 in deferred commissions. These significant fees reduce the net proceeds available for the business combination and can influence deal structuring.
• Limited Operating History [medium — operational]: As a newly formed entity with no operating history, Legato Merger Corp. IV has not generated revenue or profits. Its future success is entirely dependent on the execution of its business combination strategy and the performance of the acquired entity.
• Potential Conflicts of Interest [medium — legal]: The low purchase price of founder shares and the structure of deferred underwriting commissions may create conflicts of interest for initial shareholders and the underwriter, potentially prioritizing deal completion over maximizing value for public shareholders.

Industry Context

Legato Merger Corp. IV targets high-growth sectors including infrastructure, industrial, artificial intelligence, and technology. These industries are characterized by rapid innovation, significant capital requirements, and intense competition. The AI and technology sectors, in particular, are experiencing substantial investment and M&A activity, driven by advancements in machine learning, cloud computing, and data analytics. Companies in these fields often require substantial funding to scale operations and R&D, making them attractive targets for SPACs seeking to leverage public market capital.

Regulatory Implications

SPACs are subject to SEC regulations and evolving disclosure requirements. The low cost basis of founder shares and the potential for conflicts of interest are areas of increased scrutiny by regulators. Investors must be aware of the heightened risks associated with SPACs, including potential for market manipulation and the need for robust due diligence on target companies.

What Investors Should Do

1. Assess management's track record and deal sourcing capabilities.
2. Evaluate the potential for dilution from founder shares and warrants.
3. Understand the redemption rights and the implications of the 24-month deadline.
4. Consider the impact of underwriting fees and deferred commissions on deal value.

Key Dates

• N/A: IPO Filing — Initiates the public offering process for Legato Merger Corp. IV.
• N/A: IPO Closing — Funds are raised, and shares/warrants begin trading publicly.
• Within 24 months of IPO Closing: Deadline to complete business combination — Failure to complete a business combination by this date triggers redemption of public shares.
• Within 27 months of IPO Closing (with LOI): Extended deadline to complete business combination — Provides additional time if a letter of intent is signed.

Glossary

SPAC

Special Purpose Acquisition Company. A shell company that raises capital through an IPO to acquire an existing company. (Legato Merger Corp. IV is a SPAC.)

Units

A security comprising one ordinary share and a fraction of a warrant. (The IPO is structured as a sale of units.)

Warrants

A security that gives the holder the right, but not the obligation, to purchase shares at a specified price (exercise price) before a certain expiration date. (Each unit includes a warrant exercisable at $11.50.)

Founder Shares

Shares issued to the SPAC's sponsors or initial shareholders at a nominal cost before the IPO. (Initial shareholders hold 7,666,667 founder shares at a very low cost basis.)

Redemption

The right of public shareholders to have their shares repurchased by the SPAC, typically at the IPO price, if a business combination is not completed. (Public shareholders can redeem shares if the 24-month deadline is missed.)

Deferred Commissions

A portion of the underwriting fees that is paid to the underwriter only upon the successful completion of a business combination. ($7,000,000 of the underwriting fees are deferred.)

Trust Account

An account where the proceeds from the IPO are held in trust, typically invested in U.S. Treasury securities, until a business combination is completed or the SPAC liquidates. (Redeemed shares are paid from the trust account.)

Business Combination

The acquisition or merger of the SPAC with an operating company. (The primary objective of the SPAC is to complete a business combination.)

Year-Over-Year Comparison

This is the initial S-1 filing for Legato Merger Corp. IV, so there is no prior filing to compare financial metrics against. Key aspects to monitor will be the progress towards identifying a target company, the terms of any proposed business combination, and the potential impact of redemptions on the capital structure post-merger.

Key Financial Figures

• $200,000,000 — o Completion, dated December 19, 2025 $200,000,000 Legato Merger Corp. IV 20,000,000 U
• $10.00 — nit that we are offering has a price of $10.00 and consists of one ordinary share and
• $11.50 — rchase one ordinary share at a price of $11.50 per share. Each warrant will become exe
• $100,000 — t previously released to us (less up to $100,000 for our liquidation expenses), divided
• $25,000 — ring for an aggregate purchase price of $25,000, or approximately $0.003 per share. Sin
• $0.003 — hase price of $25,000, or approximately $0.003 per share. Since our initial shareholde
• $5,150,000 — per unit for a total purchase price of $5,150,000 in a private placement that will occur
• $5,000 — ive Officer and Chief Financial Officer $5,000 per month for serving in such capacitie
• $1,500,000 — our initial business combination, up to $1,500,000 of such loans may be convertible into p
• $0.35 — $ 190,000,000 (1) Includes up to $0.35 per unit, or up to $7,000,000 in the ag
• $7,000,000 — Includes up to $0.35 per unit, or up to $7,000,000 in the aggregate, or up to $8,050,000 i
• $8,050,000 — o $7,000,000 in the aggregate, or up to $8,050,000 if the over-allotment option is exercis
• $230,000,000 — ering, an aggregate of $200,000,000 (or $230,000,000 if the over-allotment option is exercis
• $40.8 million — or “Arpeggio,” which raised $40.8 million in June 2004 and consummated a business
• $41.4 million — or “Rhapsody,” which raised $41.4 million in October 2006 and consummated a busin

Filing Documents

• legatomerger4_s1.htm (S-1) — 1506KB
• legatomerger4_ex1-1.htm (EX-1.1) — 227KB
• legatomerger4_ex4-1.htm (EX-4.1) — 34KB
• legatomerger4_ex4-2.htm (EX-4.2) — 32KB
• legatomerger4_ex4-3.htm (EX-4.3) — 35KB
• legatomerger4_ex4-4.htm (EX-4.4) — 89KB
• legatomerger4_ex5-2.htm (EX-5.2) — 12KB
• legatomerger4_ex10-1.htm (EX-10.1) — 47KB
• legatomerger4_ex10-2.htm (EX-10.2) — 132KB
• legatomerger4_ex10-3.htm (EX-10.3) — 15KB
• legatomerger4_ex10-4.htm (EX-10.4) — 88KB
• legatomerger4_ex10-5i.htm (EX-10.5(1)) — 34KB
• legatomerger4_ex10-5ii.htm (EX-10.5(2)) — 36KB
• legatomerger4_ex10-6.htm (EX-10.6) — 16KB
• legatomerger4_ex10-7.htm (EX-10.7) — 73KB
• legatomerger4_ex14.htm (EX-14) — 58KB
• legatomerger4_ex23-1.htm (EX-23.1) — 2KB
• legatomerger4_ex99-1.htm (EX-99.1) — 29KB
• legatomerger4_ex99-2.htm (EX-99.2) — 21KB
• legatomerger4_ex99-3.htm (EX-99.3) — 29KB
• legatomerger4_ex99-4.htm (EX-99.4) — 37KB
• legatomerger4_ex107.htm (EX-FILING FEES) — 37KB
• 0001829126-25-010198.txt ( ) — 2744KB
• legatomerger4_ex107_htm.xml (XML) — 20KB

Risk Factors

Risk Factors 27 Cautionary Note Regarding Forward Looking Statements 54

Use of Proceeds

Use of Proceeds 55 Dividend Policy 59

Dilution

Dilution 60 Capitalization 62 Management’s Discussion and Analysis of Financial Condition and Results of Operations 63 Proposed Business 67 Management 81 Principal Shareholders 93 Certain Transactions 96

Description of Securities

Description of Securities 99 Shares Eligible for Future Sale 112 Taxation 114

Underwriting

Underwriting 124 Legal Matters 134 Experts 134 Where You Can Find Additional Information 134 Index to Financial Statements F-1 i Table of Contents PROSPECTUS SUMMARY This summary only highlights the more detailed information appearing elsewhere in this prospectus. As this is a summary, it does not contain all of the information that you should consider in making an investment decision. You should read this entire prospectus carefully, including the information under “Risk Factors” and our financial statements and the related notes included elsewhere in this prospectus, before investing. References in this prospectus to “we,” “us” or “our company” refer to Legato Merger Corp. IV. References in this prospectus to the “Companies Act” are to the Companies Act (As Revised) of the Cayman Islands as the same may be amended from time to time. References in this prospectus to our “public shares” are to the ordinary shares sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market) and references to “public shareholders” refer to the holders of our public shares, including our officers and directors to the extent they purchase public shares, provided that their status as “public shareholders” shall exist only with respect to such public shares. References in this prospectus to our “management” or our “management team” refer to our officers and directors and references to our “initial shareholders” are to our shareholders prior to this offering (excluding BTIG). The term “equity-linked securities” refers to any debt or equity securities issued in a transaction, including but not limited to a private placement of equity or debt, that are convertible, exercisable or exchangeable for ordinary shares. Unless we tell you otherwise, the information in this

View Full Filing

View this S-1 filing on SEC EDGAR